Skip to main content
Close
Home
Presented by
  • MDedge Neurology
Home
Full Menu Full Menu
  • Clinical Topics
  • Conference Coverage
  • Literature Review
  • MD-IQ
  • Clinical Edge Journal Scan

Expert Perspectives

June 14, 2022

Sex Differences in MS

June 14, 2022
Patricia K. Coyle, MD, FAAN, FANA
Patricia K. Coyle, MD, FAAN, FANA
June 14, 2022
ICYMI Multiple Sclerosis
April 14, 2022

The Enigma of MS Etiology: Find an Answer, Ask More Questions

April 14, 2022
Ahmed Z. Obeidat, MD, PhD
Ahmed Z. Obeidat, MD, PhD
April 14, 2022
ICYMI Multiple Sclerosis
March 9, 2022

Do Not Expect a Patient With MS to Have Just MS

March 9, 2022
Ruth Ann Marrie, MD, PhD, FRCPC, FCAHS
Ruth Ann Marrie, MD, PhD, FRCPC, FCAHS
March 9, 2022
ICYMI Multiple Sclerosis
Read More

Clinical Edge Journal Scan

May 27, 2022

Commentary: COVID-19 Treatment and Disease-Modifying Therapies in MS, June 2022

May 27, 2022
Mark Gudesblatt, MD
Mark Gudesblatt, MD
May 27, 2022
ICYMI Multiple Sclerosis
May 18, 2022

Multiple sclerosis type and female sex predict worsening lower urinary tract symptoms

May 18, 2022
May 18, 2022
ICYMI Multiple Sclerosis
May 18, 2022

Multiple sclerosis: Reduced humoral response contributes to breakthrough SARS-CoV-2 infection in patients on DMTs

May 18, 2022
May 18, 2022
ICYMI Multiple Sclerosis
May 18, 2022

T-cell response after third SARS-CoV-2 vaccination in patients with MS on ocrelizumab

May 18, 2022
May 18, 2022
ICYMI Multiple Sclerosis
Read More

MD-IQ

Multiple Sclerosis and Women's Health

Vitamin D Deficiency and Multiple Sclerosis

Multiple Sclerosis and Mental Health Comorbidities

Multiple sclerosis and COVID-19

More

Clinical Topics

June 22, 2022

COVID vaccination in DMT-treated MS patients: New data

June 22, 2022
Nancy A. Melville
Nancy A. Melville
June 22, 2022
CMSC: Consortium of Multiple Sclerosis Centers
ICYMI Multiple Sclerosis
June 3, 2022

B-cell level may affect COVID booster efficacy in MS

June 3, 2022
Kelli Whitlock Burton
Kelli Whitlock Burton
June 3, 2022
ICYMI Multiple Sclerosis
April 20, 2022

Childhood abuse may increase risk of MS in women

April 20, 2022
Will Pass
Will Pass
April 20, 2022
ICYMI Multiple Sclerosis
October 28, 2021

MS fundraising during a pandemic

October 28, 2021
Glenn Williams
Glenn Williams
October 28, 2021
ICYMI Multiple Sclerosis
Read More

Literature Review

April 20, 2022

Childhood abuse may increase risk of MS in women

April 20, 2022
Will Pass
Will Pass
April 20, 2022
ICYMI Multiple Sclerosis
September 1, 2021

MS plus depression can increase risk of death, vascular disease

September 1, 2021
Steve Cimino
Steve Cimino
September 1, 2021
ICYMI Multiple Sclerosis
August 30, 2021

MRI is a poor disability predictor in secondary progressive MS

August 30, 2021
Erik Greb
Erik Greb
August 30, 2021
ICYMI Multiple Sclerosis
August 26, 2021

Progressive disability in MS explained?

August 26, 2021
Erik Greb
Erik Greb
August 26, 2021
ICYMI Multiple Sclerosis
March 16, 2021

Neurologic drug prices jump 50% in five years

March 16, 2021
Erik Greb
Erik Greb
March 16, 2021
ICYMI Multiple Sclerosis
Read More

Conference Coverage

June 13, 2022

Risk of drug interactions is on the rise as MS drugs evolve

June 13, 2022
Randy Dotinga
Randy Dotinga
June 13, 2022
CMSC: Consortium of Multiple Sclerosis Centers
ICYMI Multiple Sclerosis
June 13, 2022

Consider the wider picture in relapsing remitting MS

June 13, 2022
Randy Dotinga
Randy Dotinga
June 13, 2022
CMSC: Consortium of Multiple Sclerosis Centers
ICYMI Multiple Sclerosis
June 10, 2022

Inebilizumab beneficial across genotypes in NMOSD

June 10, 2022
Nancy A. Melville
Nancy A. Melville
June 10, 2022
CMSC: Consortium of Multiple Sclerosis Centers
ICYMI Multiple Sclerosis
June 7, 2022

Stem cell transplants for MS are a ‘reasonable option,’ but questions persist

June 7, 2022
Randy Dotinga
Randy Dotinga
June 7, 2022
CMSC: Consortium of Multiple Sclerosis Centers
ICYMI Multiple Sclerosis
June 7, 2022

MS and COVID-19: Conflicting signs on risk but some trends are clearer

June 7, 2022
Randy Dotinga
Randy Dotinga
June 7, 2022
CMSC: Consortium of Multiple Sclerosis Centers
ICYMI Multiple Sclerosis
June 6, 2022

Non-White subjects are sparse in DMT trials for MS

June 6, 2022
Randy Dotinga
Randy Dotinga
June 6, 2022
CMSC: Consortium of Multiple Sclerosis Centers
ICYMI Multiple Sclerosis
April 11, 2022

Neighborhood-level data sheds new light on racial and ethnic diversity in MS

April 11, 2022
Jim Kling
Jim Kling
April 11, 2022
AAN: American Academy of Neurology
ICYMI Multiple Sclerosis
April 5, 2022

Keto diet in MS tied to less disability, better quality of life

April 5, 2022
Megan Brooks
Megan Brooks
April 5, 2022
AAN: American Academy of Neurology
ICYMI Multiple Sclerosis
Read More

This Publication

  • MDedge Neurology
  • Clinical Neurology News
  • MD-IQ

Top Sections

  • Clinical Topics & News
  • Conference Coverage
  • Literature Monitor
  • Literature Review

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Menu Presented by
Menu Close
  • Clinical Topics
  • Conference Coverage
  • Expert Perspectives
  • Literature Review
  • MD-IQ
  • Clinical Edge Journal Scan

More

  • MDedge Neurology